An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A guy in his mid-50s posted a three-year update about his weight while using Mounjaro. He says he started at about 260 pounds and is now 174, aiming for 160. He describes being “in food noise” — meaning he still notices food and is around food situations, but he feels in control and continues to lose weight slowly. He tells people he’s on Mounjaro and praises how well it’s worked for him. Mounjaro is the brand name for tirzepatide, which is a type of drug called a peptide. Peptides are small chains of amino acids — think of them as tiny biological signals. Tirzepatide acts like gut hormones that tell your brain you’re full and help control blood sugar. It’s used for treating type 2 diabetes and has become known because it also causes substantial weight loss for many people. The post is a personal testimonial, not a clinical study. It’s one person reporting steady weight loss over three years while using tirzepatide and having type 2 diabetes. That’s an encouraging individual result, but it doesn’t prove the same outcome for everyone. Clinical trials of tirzepatide have shown significant weight loss for many participants, but the reddit post itself is just anecdote — useful for illustrating a lived experience, not for measuring average effects, side effects, or long-term safety across diverse people. Why this matters is practical: people with obesity or type 2 diabetes are looking for tools that make weight loss sustainable and manageable around normal life and food. A drug that reduces appetite, improves blood sugar control, and leads to gradual weight loss can change daily life for someone who has struggled for years. For someone considering treatment, stories like this can be motivating and help set expectations that progress may be steady rather than immediate. There are important caveats. Tirzepatide is a prescription medication with side effects like nausea, diarrhea, constipation, and possible risks to the pancreas or gallbladder in some people. Long-term effects are still being studied. It’s not a magic bullet: stopping the drug can lead to weight regain, and lifestyle factors still matter. Only a clinician can decide if it’s appropriate based on medical history, other medications, and overall risk. Finally, an individual’s report doesn’t replace scientific evidence; it’s one data point among many. Bottom line: this personal three-year report shows impressive, steady weight loss while on Mounjaro, but it’s an anecdote — promising and informative for people curious about tirzepatide, yet not a substitute for medical advice or broader clinical data.
Source: r/Mounjaro